The cancer biomarker IDO1 has been reported to increase the conversion of Trp to Kyn10–12, which implies that non-invasive sampling of the Trp/Kyn ratio from the skin surface is a promising skin cancer biomarker. This evidence concerns the gene IDO1 and skin cancer.